Literature DB >> 2171602

Cyclophosphamide, doxorubicin and vincristine with amphotericin B in sonicated liposomes as salvage therapy for small cell lung cancer.

J P Sculier, J Klastersky, P Libert, P Ravez, D Brohee, G Vandermoten, J Michel, J Thiriaux, G Bureau, J Schmerber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2171602     DOI： 10.1016/0277-5379(90)90203-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

Review 1.  Small cell lung cancer: past, present, and future.

Authors:  Estelamari Rodriguez; Rogerio C Lilenbaum
Journal:  Curr Oncol Rep       Date:  2010-09       Impact factor: 5.075

2.  Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer.

Authors:  Sang Ok Jung; Sun Young Kim; Ju-Ock Kim; Sung Soo Jung; Hee Sun Park; Jae Young Moon; Sung Min Kim; Jeong Eun Lee
Journal:  Thorac Cancer       Date:  2015-01-27       Impact factor: 3.500

3.  Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer.

Authors:  K Goto; I Sekine; Y Nishiwaki; R Kakinuma; K Kubota; T Matsumoto; H Ohmatsu; S Niho; T Kodama; T Shinkai; T Tamura; Y Ohe; H Kunitoh; N Yamamoto; H Nokihara; K Yoshida; T Sugiura; K Matsui; N Saijo
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.